• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨块型肝癌的特征。

Features of massive hepatocellular carcinomas.

机构信息

Departments of aHCC Biology bEpidemiology, IRCCS S. de Bellis, National Institute for Digestive Diseases, Castellana Grotte (BA), Italy.

出版信息

Eur J Gastroenterol Hepatol. 2014 Jan;26(1):101-8. doi: 10.1097/MEG.0b013e3283644c49.

DOI:10.1097/MEG.0b013e3283644c49
PMID:23863262
Abstract

BACKGROUND

Massive hepatocellular carcinomas (HCCs) are uncommon and poorly characterized.

AIM

To characterize a large cohort of HCC patients with massive tumors, with documented baseline characteristics and survival data.

METHODS

Records were examined of a cohort of 344 biopsy-proven and randomly presenting unresectable HCC patients with tumors of at least 10 cm diameter (massive), which were analyzed for their clinical characteristics and survival.

RESULTS

Massive HCC patients were significantly different from others, in having less severe cirrhosis and higher blood platelet counts, α-fetoprotein (AFP), alkaline phosphatase (ALKP), and γ-glutamyl transpeptidase (GGTP) levels. Platelets, ALKP, and GGTP correlated with tumor size. Within massive HCCs, ALKP levels related to tumor number, whereas platelet counts related to tumor size. AFP and GGTP related to neither. All four parameters related to survival. A multivariate Cox proportional hazard model showed that ALKP and AFP were significant for overall survival. Survival of massive tumors was not significantly worse than for other larger tumors.

CONCLUSION

Massive HCCs were characterized by high blood platelets, AFP, ALKP, and GGTP levels. AFP levels were important for survival, but did not directly relate to tumor size or number, suggesting that AFP represents some other property of massive HCC biology. Patients with massive HCC should thus be considered for active therapeutic intervention, just as for other sizes of HCC.

摘要

背景

巨块型肝癌(HCC)较为少见且特征不明显。

目的

对大量巨块型 HCC 患者的基线特征和生存数据进行描述。

方法

分析了 344 例经活检证实且随机出现的无法切除的 HCC 患者的记录,这些患者的肿瘤直径至少为 10cm(巨块型),对其临床特征和生存情况进行了分析。

结果

与其他 HCC 患者相比,巨块型 HCC 患者的肝硬化程度较轻,血小板计数、甲胎蛋白(AFP)、碱性磷酸酶(ALKP)和γ-谷氨酰转肽酶(GGTP)水平较高。血小板、ALKP 和 GGTP 与肿瘤大小相关。在巨块型 HCC 中,ALKP 水平与肿瘤数量相关,而血小板计数与肿瘤大小相关。AFP 和 GGTP 均与两者无关。所有四个参数均与生存相关。多变量 Cox 比例风险模型显示,ALKP 和 AFP 对总生存有显著影响。巨块型肿瘤的生存并未明显差于其他更大的肿瘤。

结论

巨块型 HCC 具有较高的血小板、AFP、ALKP 和 GGTP 水平。AFP 水平对生存很重要,但与肿瘤大小或数量没有直接关系,这表明 AFP 代表了巨块型 HCC 生物学的其他一些特性。因此,应考虑对巨块型 HCC 患者进行积极的治疗干预,就像对其他大小的 HCC 患者一样。

相似文献

1
Features of massive hepatocellular carcinomas.巨块型肝癌的特征。
Eur J Gastroenterol Hepatol. 2014 Jan;26(1):101-8. doi: 10.1097/MEG.0b013e3283644c49.
2
Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma.肝癌患者血小板减少与肿瘤大小的关系。
Oncology. 2012;83(6):339-45. doi: 10.1159/000342431. Epub 2012 Sep 18.
3
Low alpha-fetoprotein HCC and the role of GGTP.低甲胎蛋白肝癌与γ-谷氨酰转肽酶的作用
Int J Biol Markers. 2014 Dec 9;29(4):e395-402. doi: 10.5301/jbm.5000092.
4
Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase.肝癌大小:血小板、γ-谷氨酰转肽酶和碱性磷酸酶。
Oncology. 2013;85(3):153-9. doi: 10.1159/000354416. Epub 2013 Aug 29.
5
Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.血小板计数及基于血小板的模型对肝细胞癌复发的意义
World J Gastroenterol. 2015 May 14;21(18):5607-21. doi: 10.3748/wjg.v21.i18.5607.
6
Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.经肝动脉化疗栓塞治疗后 AFP 状态对肝细胞癌结局的预后意义。
Ann Surg Oncol. 2012 Oct;19(11):3540-6. doi: 10.1245/s10434-012-2368-5. Epub 2012 Apr 25.
7
Significance of platelet and AFP levels and liver function parameters for HCC size and survival.血小板、甲胎蛋白水平及肝功能参数对肝癌大小和生存的意义。
Int J Biol Markers. 2014 Sep 30;29(3):e215-23. doi: 10.5301/jbm.5000064.
8
Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.肝癌的化疗栓塞:362 例患者队列中肿瘤反应和生存的多因素分析预测因素。
J Vasc Interv Radiol. 2011 Jul;22(7):917-23. doi: 10.1016/j.jvir.2011.03.005. Epub 2011 May 14.
9
Low alpha-fetoprotein hepatocellular carcinoma.低甲胎蛋白肝细胞癌。
J Gastroenterol Hepatol. 2010 Sep;25(9):1543-9. doi: 10.1111/j.1440-1746.2010.06303.x.
10
Significance of increased serum GGTP levels in HCC patients.肝癌患者血清γ-谷氨酰转肽酶水平升高的意义。
Hepatogastroenterology. 2010 Jul-Aug;57(101):869-74.

引用本文的文献

1
Efficacy and safety of D-TACE followed by D-RFA for unresectable large hepatocellular carcinoma.经动脉化疗栓塞术(D-TACE)联合射频消融术(D-RFA)治疗不可切除性大肝细胞癌的疗效与安全性
Front Oncol. 2025 Jul 28;15:1530951. doi: 10.3389/fonc.2025.1530951. eCollection 2025.
2
Tumor marker pseudoprogression and immune-related cholangitis during conversion therapy for massive hepatocellular carcinoma: a case report.巨大肝细胞癌转化治疗期间的肿瘤标志物假性进展及免疫相关胆管炎:一例报告
Front Immunol. 2025 Jun 4;16:1529016. doi: 10.3389/fimmu.2025.1529016. eCollection 2025.
3
Comparative analysis of efficacy and safety between D-TACE + HAIC + lenvatinib and D-TACE + lenvatinib in the treatment of unresectable massive hepatocellular carcinoma.
D-TACE+HAIC+乐伐替尼与 D-TACE+乐伐替尼治疗不可切除的大肝癌的疗效和安全性比较分析。
BMC Cancer. 2024 Nov 18;24(1):1422. doi: 10.1186/s12885-024-13179-5.
4
Identification of 2 large size HCC phenotypes, with and without associated inflammation.识别出两种大尺寸肝癌表型,一种伴有炎症,另一种不伴有炎症。
Clin Pract (Lond). 2022;19(4):1953-1958. Epub 2022 Jun 7.
5
Development and validation of web-based prognostic nomograms for massive hepatocellular carcinoma (≥10 cm): A retrospective study based on the SEER database.基于 SEER 数据库的回顾性研究:开发和验证用于巨块型肝细胞癌(≥10cm)的基于网络的预后列线图。
Cancer Med. 2023 Jun;12(12):13167-13181. doi: 10.1002/cam4.6003. Epub 2023 Apr 27.
6
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs.大肝癌患者临床表型及相关生存情况的识别
Cancers (Basel). 2021 Feb 3;13(4):592. doi: 10.3390/cancers13040592.
7
Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis.γ-谷氨酰转移酶在肝细胞癌患者中的预后及临床病理意义:一项遵循PRISMA规范的荟萃分析。
Medicine (Baltimore). 2019 May;98(19):e15603. doi: 10.1097/MD.0000000000015603.
8
Transcatheter arterial chemoembolization monotherapy vs combined transcatheter arterial chemoembolization-percutaneous microwave coagulation therapy for massive hepatocellular carcinoma (≥10 cm).经导管动脉化疗栓塞术单药治疗与经导管动脉化疗栓塞术联合经皮微波凝固疗法治疗巨大肝细胞癌(≥10厘米)的对比
Cancer Manag Res. 2018 Nov 1;10:5273-5282. doi: 10.2147/CMAR.S172395. eCollection 2018.
9
The prognostic significance of pretreatment serum γ-glutamyltranspeptidase in primary liver cancer: a meta-analysis and systematic review.术前血清γ-谷氨酰转肽酶对原发性肝癌的预后意义:荟萃分析和系统评价。
Biosci Rep. 2018 Nov 28;38(6). doi: 10.1042/BSR20181058. Print 2018 Dec 21.
10
Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1.对胰岛素样生长因子-1介导的多激酶抑制剂作用的抗性。
J Exp Clin Cancer Res. 2015 Sep 2;34(1):90. doi: 10.1186/s13046-015-0210-1.